von Willebrand factor and thrombosis

被引:72
作者
Franchini, Massimo
Lippi, Giuseppe
机构
[1] Osped Policlin, Serv Immunoematol & Trasfusione, I-37134 Verona, Italy
[2] Univ Verona, Dipartimento Sci Biomed & Morfol, Ist Chim & Microscopia Clin, Verona, Italy
关键词
von Willebrand factor; thrombosis; thrombotic thrombocytopenic purpura; von Willebrand disease;
D O I
10.1007/s00277-006-0085-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
There is increasing evidence that von Willebrand factor (VWF), an adhesive multimeric protein that has an important function in primary hemostasis and as a carrier of factor VIII, has a pivotal role in thrombogenesis. In fact, while the presence in plasma of unusually large VWF multimers due to a congenital or acquired deficiency of a VWF-cleaving metalloprotease has been implicated in the pathogenesis of thrombotic thrombocytopenic purpura (TTP), high plasma levels of VWF have been associated with a slightly increased risk of arterial thrombosis. With regard to the association between VWF and venous thrombosis, clear conclusions cannot yet be drawn from the conflicting published data. Patients with von Willebrand disease, an inherited hemorrhagic disorder, may also paradoxically experience thrombotic events as a result of interactions among multiple prothrombotic risk factors. After a description of the structure and physiology of VWF, all these aspects are discussed in the present review.
引用
收藏
页码:415 / 423
页数:9
相关论文
共 81 条
[1]   IMMUNOHISTOCHEMISTRY OF VASCULAR LESION IN THROMBOTIC THROMBOCYTOPENIC PURPURA, WITH SPECIAL REFERENCE TO FACTOR-VIII RELATED ANTIGEN [J].
ASADA, Y ;
SUMIYOSHI, A ;
HAYASHI, T ;
SUZUMIYA, J ;
KAKETANI, K .
THROMBOSIS RESEARCH, 1985, 38 (05) :469-479
[2]   Myocardial infarction following recombinant activated factor VII in a patient with type 2A von Willebrand disease [J].
Basso, IN ;
Keeling, D .
BLOOD COAGULATION & FIBRINOLYSIS, 2004, 15 (06) :503-504
[3]  
BOND L, 1988, NEW ENGL J MED, V318, P121
[4]   DEEP VENOUS THROMBOSIS AND PULMONARY-EMBOLISM IN A PATIENT WITH TYPE-III VONWILLEBRANDS DISEASE, PROTEIN-C AND ANTITHROMBIN-III DEFICIENCY [J].
BOWEN, D ;
DASANI, H ;
YUNG, B ;
BLOOM, A .
BRITISH JOURNAL OF HAEMATOLOGY, 1992, 81 (03) :446-447
[5]   Thrombus precursor protein, endogenous thrombin potential, von-Willebrand factor and activated factor VII in suspected deep vein thrombosis: is there a place for new parameters? [J].
Bucek, RA ;
Reiter, M ;
Quehenberger, P ;
Weltermann, A ;
Kyrle, PA ;
Minar, E .
BRITISH JOURNAL OF HAEMATOLOGY, 2003, 120 (01) :123-128
[6]   THROMBOSIS FOLLOWING DESMOPRESSIN FOR UREMIC BLEEDING [J].
BYRNES, JJ ;
LARCADA, A ;
MOAKE, JL .
AMERICAN JOURNAL OF HEMATOLOGY, 1988, 28 (01) :63-65
[7]  
Castaman G, 2003, HAEMATOLOGICA, V88, P94
[8]  
Cattaneo M, 2001, HAEMATOLOGICA, V86, P346
[9]   ADAMTS-13 rapidly cleaves newly secreted ultralarge von Willebrand factor multimers on the endothelial surface under flowing conditions [J].
Dong, JF ;
Moake, JL ;
Nolasco, L ;
Bernardo, A ;
Arceneaux, W ;
Shrimpton, CN ;
Schade, AJ ;
McIntire, LV ;
Fujikawa, K ;
López, JA .
BLOOD, 2002, 100 (12) :4033-4039
[10]  
DULHOSTE MN, 1989, ARCH MAL COEUR VAISS, V82, P1875